FAK and PYK2 are involved in overlapping signaling pathways, implicated in the development of tumor malignancy; PYK2 is upregulated upon deletion or inhibition of FAK to compensate for the loss of FAK activity [17, 21, 22]. Here, PTK2 is linked to neoplasm.